International journal of public health · 2026
Bringing Cervical Cancer Screening Closer to Women: Feasibility of Artificial Intelligence and Remote Assessment in Primary Health Care.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Shamsunder Saritha, Digumarti Leela, Nayak Bhagyalaxmi, Dasari Vasantha, Mishra Archana, Kumar Anita, Nanda Sony, Kishore Jugal, Choudhary Nishi
Аннотация
OBJECTIVE: The objective was to assess the feasibility of image-based methods for screening and triaging women in a single visit by: (i) a trained but inexperienced nurse, (ii) remote expert review via a web system, (iii) an artificial intelligence (AI) model.
METHODS: Sexually active, non-pregnant women (25-65 years) were screened using visual inspection method Cervical images captured with Smart Scope® CX were assessed independently by nurses, remote experts, and AI, with assessors blinded to each other. Referrals for colposcopy were based on remote expert evaluations followed by colposcopy/biopsy.
RESULTS: Among 871 women screened, AI identified 205 positives; experts identified 201. Colposcopy was performed on 69 women, 40 of them had a biopsy. Compared to histopathology, AI achieved 86.7% sensitivity, 92.0% specificity, and 90.0% accuracy (AUC = 0.894). Remote experts showed high sensitivity (86.7%) but low specificity (32%) and accuracy (52.5%).
CONCLUSION: This study provides proof of concept for the feasibility of the AI-driven Smart Scope® CX test as a single-visit "screen-and-triage" tool in primary healthcare settings. Additionally, remote expert assessment demonstrating performance comparable to colposcopy indicates its potential as an alternative triage method in low-resource settings.
METHODS: Sexually active, non-pregnant women (25-65 years) were screened using visual inspection method Cervical images captured with Smart Scope® CX were assessed independently by nurses, remote experts, and AI, with assessors blinded to each other. Referrals for colposcopy were based on remote expert evaluations followed by colposcopy/biopsy.
RESULTS: Among 871 women screened, AI identified 205 positives; experts identified 201. Colposcopy was performed on 69 women, 40 of them had a biopsy. Compared to histopathology, AI achieved 86.7% sensitivity, 92.0% specificity, and 90.0% accuracy (AUC = 0.894). Remote experts showed high sensitivity (86.7%) but low specificity (32%) and accuracy (52.5%).
CONCLUSION: This study provides proof of concept for the feasibility of the AI-driven Smart Scope® CX test as a single-visit "screen-and-triage" tool in primary healthcare settings. Additionally, remote expert assessment demonstrating performance comparable to colposcopy indicates its potential as an alternative triage method in low-resource settings.